Study online at https://quizlet.com/_c8lvpj
1. Hematologic -cancer that begins in bone marrow or immune system cells.
cancer (blood -Ex: leukemia, lymphoma, multiple myeloma
cancer)
2. Leukemia cancer starts in blood-forming tissues like bone marrow
-causes lots of abnormal blood cells to be produced and enter bloodstream
3. Lymphoma -cancer that begins in immune system (WBC=lymphocytes)
-hodgkin and non-hodgkins
-B lymphocytes (B cells) - make antibodies (bacteria and viruses, most common
lymphoma
-T lymphocytes (T cells) - boost/slow immune, destroy germs and abnormal cells
4. Hodgkin lym- Reed-Sternberg cell (cancer cells in classic)
phoma -typically starts in B cells
5. Non-Hodgkin's -large, diverse group of cancers in immune system cells
Lymphoma -indolent (slow growing) or aggressive (fast)
6. Myeloma Cancer in plasma cells (WBC that produce antibodies)
7. Chemotherapy All antineoplastic agents used to treat cancer, given through oral and parenteral
routes or other routes as specified in the standard, not including hormonal
therapies.
8. Who can order Written and signed by licensed independent practitioners (MD/DO, PA, Oncology
chemotherapy? NP)
9. Can you use ver- NO! Only when holding/stopping admin.
bal orders for
chemotherapy?
10. Who can mix Pharmacist, Pharmacy tech, MD/DO, qualified RN
Chemotherapy?
, Fundamentals of Chemotherapy Immunotherapy Administration
Study online at https://quizlet.com/_c8lvpj
11. Who can admin- Registered Nurses with specialized education, prep and training. See specific state
ister chemother- laws and statutes
apy?
12. How often is Annual continuing ed and competency assessment is recommended
chemo com-
petency re-
assessed>
13. What is the -confirm plan with patient
dose verification -two practitioners verify: drug name, dose, volume, rate, route, expiration date,
process? appearance
-document verification in chart
14. What PPE is re- -Gloves: two pairs, HD tested
quired for IV -Gown: disposable, back closed, long sleeved
Chemotherapy? -Respirator: NIOSH approved
-Eye & Face: face shield/mask
15. Neoadjuvant Chemo BEFORE primary treatment (common in breast and colon)
therapy (tumor
burden)fcon
16. Adjuvant therapy Chemo AFTER primary treatment (common in solid tumor)
17. conditioning or administration of chemo sometimes with total body irradiation to eliminate resid-
preparative ther- ual disease or ablate marrow space prior to stem cell transplantation
apy
18. myeloblative obliteration of bone marrow with chemo administered in high doses in prepara-
therapy tion for stem cell transplant
- lethal levels - does not allow for spontaneous stem cell regrowth - must be
followed by transplant to prevent death